14 Hrs
Source:
الاقتصادية
Swedish IQT Buys Kigen for $10.8B
Molecular Testing and Diagnostics Company "KiaGen" announced an acquisition agreement by Swedish investment firm "EQ T" valued at approximately $10.78 billion, with a premium of 8.6% over the last share price. This deal marks the end of years of speculation about the takeover of the European diagnostics company, amid rising interest from private equity firms in the healthcare sector driven by the increasing demand for molecular testing and diagnostics.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)